ORAI3 pharmacologic or molecular (siRNA) neutralization inhibits protective GSK3β phosphorylation, impairs early adaptive cardiac hypertrophy and accelerates HF [131]. The gene discussed is ORAI3; the disease is hydrops fetalis.